XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Dec. 31, 2021   71,123      
Balance at beginning of period at Dec. 31, 2021 $ 1,096,514 $ 71 $ 1,468,683 $ (357,157) $ (15,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)   228      
Issuance of common stock on exercise of stock options and vesting of restricted stock units 1,422   1,422    
Issuance of common stock under ESPP (in shares)   82      
Issuance of common stock under ESPP 2,115   2,115    
Tax portion of vested restricted stock units (1,447)   (1,447)    
Stock-based compensation expense (employee) 6,230   6,230    
Stock-based compensation expense (non-employee) 11   11    
Stock-based compensation expense (ESPP) 404   404    
Net loss (14,461)     (14,461)  
Other comprehensive income (loss) (5,598)       (5,598)
Balance at end of period (in shares) at Mar. 31, 2022   71,433      
Balance at end of period at Mar. 31, 2022 1,085,190 $ 71 1,477,418 (371,618) (20,681)
Balance at beginning of period (in shares) at Dec. 31, 2022   71,959      
Balance at beginning of period at Dec. 31, 2022 1,075,200 $ 72 1,500,191 (393,717) (31,346)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares)   332      
Issuance of common stock on exercise of stock options and vesting of restricted stock units 1,988   1,988    
Issuance of common stock under ESPP (in shares)   92      
Issuance of common stock under ESPP 1,974   1,974    
Tax portion of vested restricted stock units (2,277)   (2,277)    
Stock-based compensation expense (employee) 7,612   7,612    
Stock-based compensation expense (ESPP) 373   373    
Net loss (8,091)     (8,091)  
Other comprehensive income (loss) 4,480       4,480
Balance at end of period (in shares) at Mar. 31, 2023   72,383      
Balance at end of period at Mar. 31, 2023 $ 1,081,259 $ 72 $ 1,509,861 $ (401,808) $ (26,866)